Calluna concludes patient enrolment in Phase II trial for IPF
Topline data from the trial are expected in the first quarter of 2027.
Clinical Trials
ModeX starts dosing in MDX2003 trial for B-cell lymphoma
MSD and Eisai’s RCC combination regimens fail to meet Phase III trial endpoints
Roche reports Phase III METEOROID study results for MOGAD
Tenvie doses first subject in Phase I TNV108 trial for peripheral neuropathies
Atsena secures DMC approval for LIGHTHOUSE trial
Akamis Bio reports early data from NG-350A Phase Ib trial
Agenus announces Phase II results from gastroesophageal cancer therapy
